Population
610 patients undergoing coronary artery bypass grafting
Design
Cohort
Follow-up
average 12.1 (SD 1.5) months
Authors
Loading...
Smaller BSA may elevate CABG graft occlusion risk; leaves open whether perioperative beta-blockers improve vein patency.
Smaller body surface area is an independent risk factor for both arterial and venous graft occlusion after CABG, while perioperative beta-blocker use is associated with improved vein graft patency.
Eritsland et al. (1995) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: